CD244 levels owned the diagnostic performance in discerning immunotherapy responders in melanoma (Supplementary Fig. 6E), non-small cell lung cancer (Supplementary Fig. 6F–G) and hepatocellular carcinoma (Supplementary Fig. 6H). This evidence concerns the gene CD244 and hepatocellular carcinoma.